Correlation Between Nutritional Assessment and Clinical Outcomes in Hematologic Patients Undergoing Allo-HSCT: A GLIM-Based Study

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2400083947

Enrollment

Unknown

Registered

2024-05-08

Start date

2023-06-07

Completion date

Unknown

Last updated

2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hematologic malignancy

Interventions

allo-HSCT patient:No

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: (1) Patients diagnosed with hematologic neoplasms; (2) Plan to receive allo-HSCT treatment; (3) Suitable for body composition measurement by bioelectrical impedance analysis; (4) Agree to participate in clinical studies and sign informed consent.

Exclusion criteria

Exclusion criteria: (1) suffering from serious cardiovascular and cerebrovascular diseases, hypoxia, liver and kidney diseases, gastrointestinal diseases, endocrine system diseases, infectious diseases or mental disorders; (2) Unable to continue to complete the study or affect the results of the study due to other reasons.

Design outcomes

Primary

Measure	Time frame
albumin;prealbumin;Parameter of inflammation;Parameter of Anthropometric;Nutritional assessment scale;Body composition;	—

Secondary

Measure	Time frame
Serum amino acids;Dietary assessment;	—

Countries

China

Contacts

Public ContactChao Kang

General Hospital of Western Theater Command

spiderman123007@163.com+86 28 8657 0983

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026